Journal
FRONTIERS IN PEDIATRICS
Volume 10, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fped.2022.953150
Keywords
influenza A virus; neonatal immune response; microbiota; immunity; antiviral immunity
Categories
Funding
- Burroughs Wellcome Fund
- NIH/NIAID
- Children's Discovery Institute at St. Louis Children's Hospital
- [K08AI135097]
Ask authors/readers for more resources
Influenza causes a global epidemic every year, resulting in a significant number of deaths and impact on healthcare and the economy. Infants and children are more susceptible and have more severe symptoms, with different immune responses compared to adults. The unique immune response of the young is possibly linked to the microbiota.
Annually influenza causes a global epidemic resulting in 290,000 to 650,000 deaths and extracts a massive toll on healthcare and the economy. Infants and children are more susceptible to infection and have more severe symptoms than adults likely mitigated by differences in their innate and adaptive immune responses. While it is unclear the exact mechanisms with which the young combat influenza, it is increasingly understood that their immune responses differ from adults. Specifically, underproduction of IFN-gamma and IL-12 by the innate immune system likely hampers viral clearance while upregulation of IL-6 may create excessive damaging inflammation. The infant's adaptive immune system preferentially utilizes the Th-2 response that has been tied to gamma delta T cells and their production of IL-17, which may be less advantageous than the adult Th-1 response for antiviral immunity. This differential immune response of the young is considered to serve as a unique evolutionary adaptation such that they preferentially respond to infection broadly rather than a pathogen-specific one generated by adults. This unique function of the young immune system is temporally, and possibly mechanistically, tied to the microbiota, as they both develop in coordination early in life. Additional research into the relationship between the developing microbiota and the immune system is needed to develop therapies effective at combating influenza in the youngest and most vulnerable of our population.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available